aBSTRACT author Index 354 Wagner, M 654 Wagner-Weiner, L 464, 1673, 1691, 1702, 2017, 1677 Wahezi, DM 1673, 1691, 1692, 2017 Wahl, D 1 Wahren-Herlenius, M 832, 1322, 1579, 1885, 1917 Waimann, C 50, 941, 1047, 1865 Wainmann, C 324 Waite, P 213 Waiter, GD 649 Wakabayashi, K 26, 1773 Wakefield, I 1243, 1245 Wakefield, RJ 777, 1629, 1637, 1654 Wakeland, EK 2146 Wakhlu, A 1954 Wakitani, S 981 Waldman, T 763 Walitt, B 71, 110, 112, 117, 651, 1062 Walker, D 1064, 1186, 2082 Walker, R 1568 Walker, S 597, 1201, 1222 Walker-Bone, K 966, 1645 Wallace, CA 243, 255, 1677, 1678, 1702 Wallace, D 234, 445, 448, 451, 453, 454, 457, 471, 476, 1172, 1452, 1454, 1457, 1877, 2240, 2243 Wallace, E 694 Wallin, H 1392, 1393 Wallston, KA 115, 802 Wallwiener, D 1145 Walsh, D 676 Walsh, J 546, 967 Walsh, M 676 Walsh, NC 30, 716 Walter, M 2066 Walther, M 138 Wan, X 980 Wandinger, K-P 1174 Wang, A 971 Wang, BC 1117 Wang, C 95 Wang, D 423, 918, 1143, 1182, 1686 Wang, F 94, 105, 113 Wang, H 618 Wang, J 1119, 152, 153, 420, 442, 509, 1107, 1266, 1268, 1499, 2129, 2189 Wang, J-CE 849 Wang, K 836, 1464, 2217 Wang, L 274, 694 Wang, M 826 Wang, Q 473, 2229 2010 Program Book Wang, S 331, 1134 Wang, T 907, 1386 Wang, W 436 Wang, X 1068, 1107, 1119 Wang, Y 97, 98, 183, 192, 648, 741, 806, 813, 814, 815, 1100, 1214, 1352, 1383, 1948, 2032, 2048 Ward, M 522, 642, 786, 1039, 1784, 1982, 2185 Ward, RJ 122 Ware, M 107 Warfvinge, G 1899 Warner, M 957 Warren, RB 833 Warren, ST 250 Warriner, A 1006, 1543, 1561 Warrington, KJ 774, 1304, 2198 Wartenberg-Demand, A 1125 Warzocha, U 2034 Wasko, MC 385, 345, 386, 642, 1039, 1442 Wason, S 147 Watanabe, N 1375 Watanabe, R 139, 1300 Watanabe, T 139 Watier, H 988 Watkins, M 2251, 2252 Watson, K 421 Watson, KD 374, 1323 Watson, ME 1566 Watt, S 565 Wattiaux, M-J 2269 Webb, C 2274 Webb, R 1590 Weber, DA 306, 343 Weber, E 853, 859, 861, 1723 Wechsler, B 478, 1249, 1658, 1660 Weckerle, CE 1164 Weel, A 317, 1775, 1776, 2180 Wegner, N 1717 Wei, C 733, 1085 Wei, J 601, 617 Wei, N 1382 Wei, X-n 367 Weide, T 2237 Weidensaul, DN 331 Weijers, K 1613 Weinberger, M 1575 Weinblatt, M 41, 308, 390, 945, 946, 1050, 1102, 1119, 1335, 1610, 1753, 1778, 1782, 1805, 2064 Weingarten, TN 108 Weinstein, A 869, 1457, 2090 Weinstein, J 742 Weinstein, SP 152, 153 Weisbarth-Riedel, E 1435 Weisman, M 77, 187, 305, 471, 522, 537, 658, 1094, 1197, 1768, 1982, 2185 Weiss, A 609, 665, 1961 Weiss, H 2222 Weiss, JE 234 Weiss, P 233, 1703 Weissmann, G 1390 Weitz, M 980 Welin Henriksson, EMB 1322 Wellborne, F 1146 Wellcome Trust Case-Control Consortium 2 1355 Wells, A 727, 1120, 1212 Wells, GA 723, 794, 1758, 2108 Welsh, P 483 Welsing, PMJ 124, 380, 388, 952, 1759 Wendholt, D 1478, 1719 Wendling, D 2269, 904, 1752, 1945 Wenink, M 844, 1210 Wenting, MJG 1900 Wermuth, PJ 1993 Wernitzsch, H 886 Werth, V 920, 1198, 1213, 1521 Werther, W 1031 Wesseling, J 184 Wessels, J 2021, 2234 West, B 273 West, SG 702, 2013 Westedt, ML 663 Westerman, M 1804 Westh<strong>of</strong>f, G 1736 Westhovens, R 311, 340, 390, 520, 1120, 1829, 1836, 1837, 2170, 2214 Westlund, KN 1536 Westman, K 676, 2014 Westphal, L 44 Westra, J 1195 Wettstein, D 493 Weyand, CM 351, 1079, 2127 Weyer, M-G 911 Whalen, E 813 Whang, M-H 2158 Wheeler, M 841 Wheless, L 475 Whipple, MO 104 White, AJ 216, 1633, 1673, 2017 White, D 683, 693, 2058, 2067, 2133 White, J 1540, 1552 White, ME 1408 White, P 689, 1008, 1678, 2080 Whitfield, M 573, 675 Whitlow, HJ 694 Whitney-Mahoney, K 225 Wichuk, S 1451 Wicks, I 584, 1001, 1009, 1052, 1772 Widdifield, J 57, 313, 341 Widmer, A 895, 1425, 1435 Wiedeman, A 494, 506 Wiegant, K 1380 Wieman, M 944 Wiendl, H 1255 Wiener, HW 828 Wierenga, W 269 Wierk, A 1704 Wigler, I 697 Wigley, FM 560, 566, 587, 589, 596, 1201, 1222, 1348, 1989, 2192 Wijbrandts, C 32, 1507, 1822 Wilder, T 1469, 1470 Wildi, LM 938 Wildman, H 1990, 2193 Wildt, M 1623 Wiley, G 1586, 2144, 2146 Wilkie, R 2079, 2139 Willemze, A 2114 Williams, A 500, 827, 1591, 2145, 2148 Williams, DA 94, 650, 800 Williams, M 1122 Williams, S 321, 1526 Williams, WV 2172 Willis, CR 278 Wilson, D 931 Wilson, E 1071 Wilson, G 1756 Wilson, IB 1404 Wilson, J 934, 1608, 2149 Wilson, M 914, 1831 Wilson, N 620, 1399, 2106 Wilson, P 734, 1067 Wimmer, M 200, 2099 Windhorst, AD 1613 Winfield, JB 100, 814 Wing, H 627 Winiarska, M 994 Winkelmayer, W 2104 Winthrop, K 404, 721, 722, 758, 1643, 2103 Wipff, J 580, 1991, 2226 Wipfler-Freissmuth, E 2222 Wise, B 1385, 2212 Wise, C 255, 654, 2219 Wise, R 596, 1201, 1989 Wise, SC 289 Wisniewski, SR 2052 Wither, JE 424, 425, 429, 1874, 2190 Witko-Sarsat, V 834 Witt, MN 1781 Witte, S 392, 1123
Witte, T 824, 1578, 1579, 2214 Wittkowski, H 2002 Wluka, A 173, 183, 1383 Woby, S 646 W<strong>of</strong>sy, D 1453, 2085 Wohlreich, M 105, 113 Wolbink, G 1091, 1445, 1825, 1826, 1828 Wold, AE 1248 Wolf, D 718 Wolfe, F 89, 100, 110, 111, 112, 117, 331, 346, 651, 810, 1132 Wolff, C 1089 Wolff, R 397, 1099 Wolfson, M 1555 Wollenhaupt, J 1788, 1837, 1919 Wollman, J 697 Wollmer, P 1902 Wolvers-Tettero, I 2004 Wong, A 249, 747 Wong, B 225, 273, 288 Wong, JB 1795 Wong, LG 1870 Wong, M 428, 497 Wong, T 1772 Wong, WS 1233 Woo, J 1060 Woo, JMP 262, 998 Woo, J-H 359 Woo, P 1434 Wood, GM 1516 Wood, J 717 Wood, LS 823 Wood, PB 102 Wood, S 1129, 2171 Wood, T 573 Woods, JM 17, 39, 1131 Woodward, AL 1673, 1691, 2017 Woodward, JG 864 Woodworth, T 1474, 1766 Wooley, PH 1729 Woolf, C 1385, 1557, 2098 Wootton, J 234 Worthington, J 264, 266, 824, 829, 833, 1075, 1593, 1600, 1756, 2214, 2215 Wouters, C 1434, 1684 Wouters, D 1822 Wright, EA 2091, 2137 Wright, J 2137 Wright, N 1062 Wright, S 1434 Wright, T 560, 566, 1080, 1690 Wright, V 1681 Wrigley, T 192 Wu, E 1699 Wu, FQ 1680, 1872 Wu, HJ 1139 Wu, J 149 Wu, L 1678 Wu, M 8, 602, 603, 612 Wu, P 1168 Wu, Q 1135, 1260, 1412, 2189 Wu, R 710, 1121 Wu, W 1441 Wu, X 507, 831, 838, 1598, 1804 Wu, Z 1598 Wulffraat, NM 219 Wunrau, C 1478 Wuttge, D 1210 Wysocka, M 1198 Xavier, R 1434 Xian, H 1395 Xiang, S 944 Xiao, H 2048 Xie, F 239, 404, 721, 722, 1643, 2084, 2103 Xie, H 826 Xie, J 1772 Xie, L 86, 426 Xie, S 1412 Xing, L 712, 1492, 1710 Xu, D 28 Xu, L 1464, 1564 Xu, M 564, 592 Xu, S 443, 1114, 1190, 1996 Xu, W 386, 1097, 1114, 1943, 2264 Xu, Y 742 Xue, W 1107 X Yadav, B 1446 Yadav, MK 2086 Yagüe, J 1280 Yajima, M 1708 Yajima, N 1773 Yamada, A 921 Yamada, H 365 Yamada, M 1672 Yamada, R 1577 Yamada, S 1839 Yamada, T 1053 Yamaguchi, K-i 1783 Yamaguchi, Y 670 Yamaji, K 1731 Yamamoto, A 1511 Yamamoto, K 1577, 1814, 292, 352, 1815 Yamamoto, M 280, 1641 Yamamoto, N 1708 Yamamoto, T 619, 1467 Y Yamamura, T 896, 2232 Yamanaka, H 399, 447, 746, 897, 916, 923, 968, 1053, 1184, 1587, 1611, 1666, 1749, 1793, 1812, 1814, 1815, 1823, 1844 Yamasaki, S 364, 1371, 1632 Yamashita, H 1042, 1619 Yamauchi, K 2020 Yamazaki, H 1709 Yamazaki, Y 1672 Yan, C 330 Yan, J 1107 Yan, K 438, 2191 Yan, X 1978 Yanagida, T 1531 Yanagimachi, M 921 Yanes, J 415 Yang, B 260, 634, 1494, 2217 Yang, H 634, 1038 Yang, L 742, 1680 Yang, P 1135, 1260, 1412, 2189 Yang, S 299, 304, 1117 Yang, X 274, 1107 Yang, Y-C 971, 982 Yang, Z 1499 Yano, K 1611, 1749 Yao, C 1979 Yao, Q 1656 Yao, W 965 Yao, Z 1724 Yarboro, C 1161 Yarlagadda, S 1253 Yasuda, S 2, 5, 10, 1909, 2254 Yasukawa, M 1265, 2016 Yau, I 2019 Yavuz, S 1133, 1208, 1803 Yazbek, M 356 Yazdany, J 627, 789, 991, 2113 Yazdanyar, A 1039 Yazici, A 822 Yazici, H 84, 1288, 1312, 1697 Yazici, Y 985, 990, 1298, 1857, 1284, 1303, 1390, 1559, 1808, 1863 Ye, Z 1536 Yeleswaram, S 2172 Yelin, EH 60, 484, 627, 789, 991, 1024, 1592, 2090, 2091, 2113 Yelios<strong>of</strong>, O 1901 Yentes, JM 169 Yeo, E 13 Yeremenko, N 629, 1449 Yet Lin, L 444 Yeung, RSM 249, 267 Yew, M 2122 Yildirim, S 1279 Yildirim-Toruner, C 1191 Yildiz, Y 1970 Yilmaz, H 1282 Yilmaz, N 1208 Yilmaz, V 822, 2200 Yim, CW 477 Yin, F 1107 Yin, H 507 Yin, J 1119 Yin, M 129 Ying, J 1099, 1688 Ying, KY 477 Yip, G 1028 Yip, PSF 773 Yiu, KH 582 Yokoe, I 1797 Yokogawa, N 1907 Yokota, S 237 Yoo, B 387, 876, 2028 Yoo, D-H 359, 1941 Yoo, WH 387, 1209 Yood, RA 156, 157, 166 Yoon, JY 1813 York, M 1210, 1624 Yoshida, K 348, 511, 921, 1258, 1641 Yoshida, Y 1042 Yoshikawa, H 291, 298 Yoshimi, R 139 Yoshimura, N 1464 Yoshinari, NH 605, 887, 1644 Yoshinari, T 1814, 1815 You, X 827 Youinou, P 737, 1914, 2177, 2261 Young, JS 70 Young, NA 1374 Youssef, P 584 Yow, E 1677 Ytterberg, SR 15, 680, 934, 1304, 2012, 2068, 2198 Yu, C-M 1028 Yu, C-Y 1400, 1583, 1595 Yu, D 621, 862 Yu, J 1107, 1540, 1552 Yu, KL 467, 1667, 2159 Yu, M 2127 Yu, X 1266 Yu, Y 1107 Yuan, F 423 Yücel, AE 145, 1423 Yudoh, K 631, 652 Yue, D 1717 Yukawa, N 1377 Yuksel, A 1970 Yuksel, F 544, 666, 1283 Yurdakul, S 1279, 1288, 1697 Yusuf, E 179 Yusuf, I 741 2010 Program Book 355 abstract author Index
- Page 1 and 2:
program B O O K Pre-Conference Cour
- Page 3 and 4:
program B O O K ABOUT ACR/ARHP EDUC
- Page 5 and 6:
TABLE OF CONTENTS ACCREDITATION . .
- Page 7 and 8:
TABLE OF CONTENTS ACR/ARHP Poster S
- Page 9 and 10:
TABLE OF CONTENTS Systemic Sclerosi
- Page 11 and 12:
the written consent of the ACR is p
- Page 13 and 14:
Shuttle Bus Service See shuttle sig
- Page 15 and 16:
ACR Resource Center Hours: Sunday,
- Page 17 and 18:
ACR Hotels + Map Complimentary shut
- Page 19 and 20:
to the premier meeting in rheumatol
- Page 21 and 22:
ACR Clinical Research Conference c/
- Page 23 and 24:
4:20 PM Germinal Center Reactions A
- Page 25 and 26:
3:30 PM Live Demonstration: Ultraso
- Page 27 and 28:
Upon completion of this session, pa
- Page 29 and 30:
MONDAY, NOVEMBER 8, 2010 ACR/ARHP R
- Page 31 and 32:
B301 Dermatological Manifestations
- Page 33 and 34:
Session Overview: The innate immune
- Page 35 and 36:
Upon completion of this session, pa
- Page 37 and 38:
B308 Inflammatory Eye Disease P/C M
- Page 39 and 40:
and insufficiency • recall source
- Page 41 and 42:
Session Overview: The advent of bio
- Page 43 and 44:
2:45 pm 641. Major Improvements in
- Page 45 and 46:
5 University of Twente and Medisch
- Page 47 and 48:
ACR/ARHP Combined Abstract Session
- Page 49 and 50:
REF 25th Anniversary Celebration 2:
- Page 51 and 52:
5:45 PM 699. Defining Latent and/or
- Page 53 and 54:
Lilian H. D. van Tuyl 8 , Karin Bri
- Page 55 and 56:
ACR REF Special Sessions 4:30 - 6:0
- Page 57 and 58:
REF 5K Run/Walk 6:00 - 8:00 am See
- Page 59 and 60:
• discuss the principles of early
- Page 61 and 62:
ACR Medical Aspects of Rheumatic Di
- Page 63 and 64:
10:00 am 1349. Work as a Daily Chal
- Page 65 and 66:
ACR Plenary Session II: Discovery 2
- Page 67 and 68:
B210 B301 Pediatrics: Periodic Feve
- Page 69 and 70:
Session Overview: As a clinical edu
- Page 71 and 72:
Thomas J. Murphy Ballroom Giant Cel
- Page 73 and 74:
3:45 PM 1367. Serum Urate Levels in
- Page 75 and 76:
A411 Rheumatoid Arthritis - Human E
- Page 77 and 78:
2:45 PM 1405. Development of a Visi
- Page 79 and 80:
4:30 PM Anti-citrullinated Protein
- Page 81 and 82:
of Experimental Orthopedics, Univer
- Page 83 and 84:
5:30 PM 1438. Mortality/Morbidity i
- Page 85 and 86:
5:30 PM 1456. Belimumab, a BLyS-Spe
- Page 87 and 88:
Develly 5 , Bernardo L. F. Fernande
- Page 89 and 90:
7:30 PM Role of IL-1 in Human Artic
- Page 91 and 92:
• compare the prevalence and epid
- Page 93 and 94:
6:45 PM Macrophage Activation Syndr
- Page 95 and 96:
Upon completion of this session, pa
- Page 97 and 98:
Session Overview: This roundtable d
- Page 99 and 100:
B303 Scleroderma: Systemic Sclerosi
- Page 101 and 102:
9:00 - 10:30 am - Poster Hall Morni
- Page 103 and 104:
• describe the role of IL-1 and I
- Page 105 and 106:
Session Overview: For the clinician
- Page 107 and 108:
• identify the aspects for day-to
- Page 109 and 110:
ACR Study Groups 1:00 - 2:00 PM B30
- Page 111 and 112:
Session Overview: Ultrasound and ma
- Page 113 and 114:
Session Overview: Fifty percent of
- Page 115 and 116:
1:20 PM Academic Rheumatology Seth
- Page 117 and 118:
ACR Concurrent Abstract Sessions 2:
- Page 119 and 120:
3:00 PM 2110. Rheumatologists on th
- Page 121 and 122:
2:45 PM 2133. Reasons for Decline i
- Page 123 and 124:
Session Overview: We are witnessing
- Page 125 and 126:
Session Overview: Systemic sclerosi
- Page 127 and 128:
Oaks, CA, 2 Amgen Inc., San Francis
- Page 129 and 130:
5:00 PM 2176. A Role of Autoimmune
- Page 131 and 132:
4:30 PM 2198. Association between V
- Page 133 and 134:
ARHP Concurrent Sessions 4:30 - 6:0
- Page 135 and 136:
THURSDAY, NOVEMBER 11, 2010 ACR/ARH
- Page 137 and 138:
• apply these basic statistics to
- Page 139 and 140:
9:15 AM The ACR/EULAR Definition of
- Page 141 and 142:
Immunology, Oslo University Hospita
- Page 143 and 144:
9:15 AM 2239. Factors Associated wi
- Page 145 and 146:
Upon completion of this session, pa
- Page 147 and 148:
Mikkel Østergaard 6 , Paul Emery 4
- Page 149 and 150:
Ende 4 , 1 Department of Rheumatolo
- Page 151 and 152:
ACR Poster Session A Cytokines, Med
- Page 153 and 154:
ACR Poster Session A 51. Associatio
- Page 155 and 156:
ACR Poster Session A 83. Respirator
- Page 157 and 158:
ACR Poster Session A 121. Bone Dens
- Page 159 and 160:
ACR Poster Session A 142. The Intra
- Page 161 and 162:
ACR Poster Session A 171. Early Pro
- Page 163 and 164:
ACR Poster Session A Pediatric Rheu
- Page 165 and 166:
ACR Poster Session A 233. Prevalenc
- Page 167 and 168:
ACR Poster Session A 266. Subtype S
- Page 169 and 170:
ACR Poster Session A 297. Body Weig
- Page 171 and 172:
ACR Poster Session A 325. Patient R
- Page 173 and 174:
ACR Poster Session A 356. Influence
- Page 175 and 176:
ACR Poster Session A 383. Efficacy
- Page 177 and 178:
ACR Poster Session A 409. Rituximab
- Page 179 and 180:
ACR Poster Session A 441. Recombina
- Page 181 and 182:
ACR Poster Session A 465. Immunoglo
- Page 183 and 184:
ACR Poster Session A 496. IRF8 Alle
- Page 185 and 186:
ACR Poster Session A 521. DC-STAMP
- Page 187 and 188:
ACR Poster Session A 546. Prevalenc
- Page 189 and 190:
ACR Poster Session A 571. Epidemiol
- Page 191 and 192:
ACR Poster Session A 599. Validatio
- Page 193 and 194:
ACR/ARHP Poster Session B Halls B1
- Page 195 and 196:
ACR Poster Session B 767. Economic
- Page 197 and 198:
ACR/ARHP Poster Session B 792. The
- Page 199 and 200:
ACR/ARHP Poster Session B Universit
- Page 201 and 202:
ACR/ARHP Poster Session B 848. Cell
- Page 203 and 204:
ACR/ARHP Poster Session B 886. Scre
- Page 205 and 206:
ACR/ARHP Poster Session B 909. Regu
- Page 207 and 208:
ACR/ARHP Poster Session B 935. The
- Page 209 and 210:
ACR/ARHP Poster Session B 967. Frac
- Page 211 and 212:
ACR Poster Session B 993. Early Exp
- Page 213 and 214:
ACR/ARHP Poster Session B 1022. Com
- Page 215 and 216:
ACR/ARHP Poster Session B 1055. Son
- Page 217 and 218:
ACR Poster Session B 1084. Gene Exp
- Page 219 and 220:
ACR/ARHP Poster Session B 1111. Inc
- Page 221 and 222:
ACR Poster Session B hiroshima Memo
- Page 223 and 224:
ACR/ARHP Poster Session B 1166. Pre
- Page 225 and 226:
ACR/ARHP Poster Session B 1199. Typ
- Page 227 and 228:
ACR/ARHP Poster Session B 1225. Phy
- Page 229 and 230:
ACR/ARHP Poster Session B 1262. Lat
- Page 231 and 232:
ACR/ARHP Poster Session B 1294. End
- Page 233 and 234:
ACR/ARHP Poster Session B 1321. Cha
- Page 235 and 236:
ACR/ARHP Poster Session C Halls B1
- Page 237 and 238:
ACR/ARHP Poster Session C 1495. S10
- Page 239 and 240:
ACR/ARHP Poster Session C 1524. Inc
- Page 241 and 242:
ACR/ARHP Poster Session C 1555. Pro
- Page 243 and 244:
ACR/ARHP Poster Session C 1583. Ass
- Page 245 and 246:
ACR/ARHP Poster Session C 1596. Gen
- Page 247 and 248:
ACR/ARHP Poster Session C 1622. Flu
- Page 249 and 250:
ACR/ARHP Poster Session C Miscellan
- Page 251 and 252:
ACR/ARHP Poster Session C L. Woodwa
- Page 253 and 254:
ACR/ARHP Poster Session C 1692. Res
- Page 255 and 256:
ACR/ARHP Poster Session C 1719. Los
- Page 257 and 258:
ACR/ARHP Poster Session C 1749. Con
- Page 259 and 260:
ACR/ARHP Poster Session C 1780. Tow
- Page 261 and 262:
ACR/ARHP Poster Session C 1804. Eff
- Page 263 and 264:
ACR/ARHP Poster Session C Immunolog
- Page 265 and 266:
ACR/ARHP Poster Session C 2 Departm
- Page 267 and 268:
ACR/ARHP Poster Session C CA, 29 Un
- Page 269 and 270:
ACR/ARHP Poster Session C 1900. IL-
- Page 271 and 272:
ACR/ARHP Poster Session C 1930. Cor
- Page 273 and 274:
ACR/ARHP Poster Session C 1958. The
- Page 275 and 276:
ACR/ARHP Poster Session C 1988. Cha
- Page 277 and 278:
ACR/ARHP Poster Session C 2015. CpG
- Page 279 and 280:
ACR/ARHP Poster Session C 2038. Pri
- Page 281 and 282:
ACR/ARHP Poster Session C 2070. Ass
- Page 283 and 284:
REF Industry Roundtable-supported S
- Page 285 and 286:
REF Industry Roundtable-supported S
- Page 287 and 288:
INDUSTRY-SUPPORTED POST-CONFERENCE
- Page 289 and 290:
2010 ACR/ARHP Annual Meeting Leader
- Page 291 and 292:
2010 ACR/ARHP Annual Meeting Leader
- Page 293 and 294:
FLOOR PLANS 2010 Program Book 291
- Page 295 and 296:
VISIT THE EXHIBIT HALL New and inno
- Page 297 and 298:
EXHIBITORS La Lettre Du Rhumatologu
- Page 299 and 300:
ACKNOWLEDGEMENTS The ACR, the ARHP
- Page 301 and 302:
ACR/ARHP/REF STAFF LISTING Administ
- Page 303 and 304:
A Ahmed, Rafi, PhD T cell Memory .
- Page 305 and 306: Cooper, Max D, MD Introduction . .
- Page 307 and 308: Gerlag, Danielle Marie, MD, PhD The
- Page 309 and 310: Physical Examination Skills for Imp
- Page 311 and 312: Meroni, Pierluigi, MD Autoantibodie
- Page 313 and 314: Rogers, Joan C, PhD, OTR/ L Underst
- Page 315 and 316: Terkeltaub, Robert, MD Crystallizin
- Page 317 and 318: A Aarden, L 1825 Aarrass, S 1519, 1
- Page 319 and 320: Bakker, AAB 1095 Barendregt, B 753
- Page 321 and 322: Boutin-Le Thi Huong, D 478 Bout-Tab
- Page 323 and 324: Chatham, WW 457, 1146, 1454, 1457,
- Page 325 and 326: Daudon, M 875 Daugas, E 2009 Davatc
- Page 327 and 328: Ehst, B 758 Eicher, JL 688 Eisen, S
- Page 329 and 330: Gabay, OH 1484 Gaber, T 630, 1418 G
- Page 331 and 332: Guan, M 965 Guañabens, N 975 Gudbj
- Page 333 and 334: Homme, CL 730 Honda, E 434 Hong, JY
- Page 335 and 336: Kambayashi, T 1354 Kamdar, AA 1160
- Page 337 and 338: Kuller, LH 71 Kumabe, M 1164 Kumaga
- Page 339 and 340: Looney, C 941 Looney, MR 609 Looney
- Page 341 and 342: McCarthy, GM 1109, 1306, 1426 McCau
- Page 343 and 344: Myouzen, K 1577 Mysiw, WJ 2096 Mysl
- Page 345 and 346: Pans, M 1834 Parra, ER 605, 887 Ped
- Page 347 and 348: Radka, S 1174 Radner, H 296, 1745 R
- Page 349 and 350: Sack, KE 1898 Sacli, SF 1312 Saddic
- Page 351 and 352: 1463, 2071, 2140, 2141 Singh, K 212
- Page 353 and 354: Takahata, M 1492 Takasaki, Y 1731 T
- Page 355: 636 van Dongen, CJJ 90 Van Doornum,
- Page 359 and 360: A α-galactosylceramide 505 A2A kno
- Page 361 and 362: Behcet’s syndrome 1284, 1288, 129
- Page 363 and 364: cost-utility 759, 1539 couples 1324
- Page 365 and 366: fibroblast like synoviocyte 27 fibr
- Page 367 and 368: impact 1063, 1325 inactive disease
- Page 369 and 370: methylation 826, 1253, 1489 methylt
- Page 371 and 372: 233, 234, 240, 243, 252, 262, 268,
- Page 373 and 374: 1599, 1600, 1603, 1605, 1606, 1609,
- Page 375 and 376: 1226, 1227, 1229, 1230, 1231, 1233,
- Page 377 and 378: Abelson, Abby Goulder, MD Education
- Page 379 and 380: Massarotti, Elena M, MD Systemic Lu
- Page 381 and 382: ACR Annual Meeting fellowS-in-train
- Page 383 and 384: NOTES 2010 Program Book 381
- Page 385 and 386: Enbrel ® (etanercept) Brief Summar
- Page 387 and 388: Prescription Enbrel ® (etanercept)
Change language